"RethinkBH and Raintree are combining our strengths to deliver tools that meet the real-world needs of multidisciplinary therapy practices," said Rethink CEO Ben Semmes. "We want to make life easier ...

Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) have become a critical global public health challenge due to their high resistance to β-lactam antibiotics and association with severe ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Expanded data for VCN-01 (zabilugene almadenorepvec) in metastatic pancreatic ductal adenocarcinoma (PDAC) from the VIRAGE Phase 2b trial ...

The report identifies key market opportunities in the Plaque Psoriasis clinical trials sector by offering insights into global trial trends, prominent drug developments, and strategic investment ...

Xia, R. , Blimberg, C. , Sotelo, F. and Vandernaalt, Z. (2025) Effects of Aerobic Exercise on Physical, Mental, and Cognitive ...

Grid My Business introduces a new suite of live shareable reports, smarter review and ranking analysis, and improved data tools that simplify how businesses and agencies handle local SEO. New York, ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsGregory Demopulos - Co-Founder, Chairman, CEO ...

Introduction Burnout and reduced well-being are highly prevalent among Japanese medical students during clinical training. Scalable, evidence-based interventions are urgently needed. This protocol ...

New, Free Platform Provides an Anonymous Community for the Emotional Side of Trading DAPHNE, Ala., Nov. 11, 2025 / PRZen / Trading is often a solitary, high-stakes profession. To combat this isolation ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today ...

Third quarter 2025 revenue grew more than tenfold year-over-year and 30% sequentially quarter-over-quarter, demonstrating ...